<$BlogRSDURL$>

Wednesday, April 06, 2005

Pipeline Update: Eszopiclone in Pharmacies Now


Sepracor's new medication, Lunesta, was approved by the FDA last year.  I just heard that it is being shipped to pharmacies as of today.  I don't have a lot to add since my original post, although a couple more abstracts have appeared on Medline.  Also, I have a few comments about the potential for ancillary use of Lunesta in treatment of depression and chronic pain.  Continue reading here.